Immunome Inc. (IMNM) stock
IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.18−0.43 (-2.44%)
Close on Nov 17, 2026Market cap $1.95BP/E –Yield –
Immunome total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Immunome's total debt was $500.00K at Mar 31, 2021. For fiscal 2020 it was $500.00K.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $500.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2021 | Mar 31, 2021 | $500.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $500.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $500.00K | – |
See a number that looks wrong?